Fundraising FoxAbility
Montreal, CA · 3 known investors
Find your way into Ability
671 people in our graph share verified history with the Ability team — schools, employers, funds. One of them is your warm intro.
Samuel Hallunlockedknows Giles Day · together at Apple Tree Partners (overlapped)
knows the team · via Apple Tree Partners
knows the team · via Partners HealthCare Innovation
×2knows the team · via NewCo
×7knows the team · via Pfizer
Ability is a biotechnology company developing highly-selective, immune cell-modulating antibody therapeutics for patients with inflammatory diseases and cancer. Its AbiLeap discovery engine uses AI and a database of antibody sequences to generate fully-human monospecific and bispecific antibodies, with a lead program targeting inflammatory skin diseases and other candidates for solid tumors.
Founders & leadership
GD
Giles DayCo-founderCo-founder of Ability, a biotechnology company developing antibody therapeutics for inflammatory diseases and cancer using AI-driven discovery.
Investors · 3
AlexandriareportedPasadena
How we know: funding news · Not right? Tell us
Fonds de solidarité FTQreportedMontreal
How we know: funding news · Not right? Tell us
Frequently asked questions
- What does Ability do?
- Ability is a biotechnology company developing highly-selective, immune cell-modulating antibody therapeutics for patients with inflammatory diseases and cancer. Its AbiLeap discovery engine uses AI and a database of antibody sequences to generate fully-human monospecific and bispecific antibodies, with a lead program targeting inflammatory skin diseases and other candidates for solid tumors.
- Who founded Ability?
- Ability was founded by Giles Day.
- Who are Ability's investors?
- Ability's investors include Page One Ventures, Alexandria, Fonds de solidarité FTQ.
- Where is Ability headquartered?
- Ability is headquartered in Montreal, CA.